BridgeBio Pharma, Inc 10-Q for FY2020 Q3
BridgeBio Pharma, Inc. (BBIO)
10-Q
2020-11-05
For: 2020-09-30
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on November 5, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.13M
- down 69.6% from $26.74M a year earlier
- Net loss
- $130.17M
- compared with a net loss of $60.66M a year earlier